Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Integrated Phosphoproteome and Transcriptome Analysis Reveals Chlamydia-Induced Epithelial-to-Mesenchymal Transition in Host Cells.

Cell reports | 2019

Chlamydia trachomatis (Ctr) causes a range of infectious diseases and is epidemiologically associated with cervical and ovarian cancers. To obtain a panoramic view of Ctr-induced signaling, we performed global phosphoproteomic and transcriptomic analyses. We identified numerous Ctr phosphoproteins and Ctr-regulated host phosphoproteins. Bioinformatics analysis revealed that these proteins were predominantly related to transcription regulation, cellular growth, proliferation, and cytoskeleton organization. In silico kinase substrate motif analysis revealed that MAPK and CDK were the most overrepresented upstream kinases for upregulated phosphosites. Several of the regulated host phosphoproteins were transcription factors, including ETS1 and ERF, that are downstream targets of MAPK. Functional analysis of phosphoproteome and transcriptome data confirmed their involvement in epithelial-to-mesenchymal transition (EMT), a phenotype that was validated in infected cells, along with the essential role of ERK1/2, ETS1, and ERF for Ctr replication. Our data reveal the extent of Ctr-induced signaling and provide insights into its pro-carcinogenic potential.

Pubmed ID: 30699355 RIS Download

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ATCC (tool)

RRID:SCR_001672

Global nonprofit biological resource center (BRC) and research organization that provides biological products, technical services and educational programs to private industry, government and academic organizations. Its mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge. The primary purpose of ATCC is to use its resources and experience as a BRC to become the world leader in standard biological reference materials management, intellectual property resource management and translational research as applied to biomaterial development, standardization and certification. ATCC characterizes cell lines, bacteria, viruses, fungi and protozoa, as well as develops and evaluates assays and techniques for validating research resources and preserving and distributing biological materials to the public and private sector research communities.

View all literature mentions

ProteomeXchange (tool)

RRID:SCR_004055

A data repository for proteomic data sets. The ProteomeExchange consortium, as a whole, aims to provide a coordinated submission of MS proteomics data to the main existing proteomics repositories, as well as to encourage optimal data dissemination. ProteomeXchange provides access to a number of public databases, and users can access and submit data sets to the consortium's PRIDE database and PASSEL/PeptideAtlas.

View all literature mentions

Motif Extractor (tool)

RRID:SCR_008628

motif-x (short for motif extractor) is a software tool designed to extract overrepresented patterns from any sequence data set. The algorithm is an iterative strategy which builds successive motifs through comparison to a dynamic statistical background.

View all literature mentions

Program to Reduce Incontinence by Diet and Exercise (tool)

RRID:SCR_009018

Randomized controlled trial being conducted at two clinical centers in the United States to learn more about the effects of weight loss on urinary incontinence. About 330 overweight women aged 30 or older will participate and will be followed for 18 months. Efficacy of weight reduction as a treatment for urinary incontinence will be examined at 6 months following the intensive weight control program, and the sustained impact of the intervention will be examined at 18 months. To increase the maintenance of weight reduction and facilitate evaluation of the enduring impact of weight loss on urinary incontinence, they propose to study a motivation-based weight maintenance program. At the end of the intensive weight control program, women randomized to the weight loss program will be randomized to either a 12-month skill-based maintenance intervention or to a motivation-based maintenance intervention. The maintenance interventions maximize the potential for sustained weight loss and will allow them to determine if long-term weight reduction will produce continued improvement in urinary incontinence.

View all literature mentions

LIMMA (tool)

RRID:SCR_010943

Software package for the analysis of gene expression microarray data, especially the use of linear models for analyzing designed experiments and the assessment of differential expression.

View all literature mentions

CHOPCHOP (tool)

RRID:SCR_015723

Web application for designing gRNAs for CRISPR/Cas9 experiments. It selects target sites for CRISPR/Cas9, CRISPR/Cpf1 or TALEN-directed mutagenesis.

View all literature mentions

donkey anti-mouse IgG-HRP (antibody)

RRID:AB_641170

This polyclonal targets donkey anti-mouse IgG-HRP

View all literature mentions

Recombinant Anti-Ki67 antibody [SP6] (antibody)

RRID:AB_302459

This recombinant monoclonal targets Ki67

View all literature mentions

Purified Mouse Anti-E-cadherin (antibody)

RRID:AB_397580

This monoclonal targets E-cadherin

View all literature mentions

p63 antibody (antibody)

RRID:AB_881860

This polyclonal targets p63

View all literature mentions

HDAC2 (3F3) Mouse monoclonal Antibody (antibody)

RRID:AB_10624871

This monoclonal targets HDAC2 (3F3) Mouse mAb

View all literature mentions

EGFR (phospho Y1172) antibody (antibody)

RRID:AB_873777

This polyclonal targets EGFR (phospho Y1172)

View all literature mentions

Mouse Anti-ERK-1 / ERK-2, diphospho Monoclonal Antibody, Unconjugated, Clone MAPK-YT (antibody)

RRID:AB_477245

This monoclonal targets MAP Kinase, Activated (Diphosphorylated ERK-1&2)

View all literature mentions

MEK1/2 (47E6) Rabbit mAb (antibody)

RRID:AB_331778

This monoclonal targets MEK1/2 (47E6) Rabbit mAb

View all literature mentions

HSP60 (bacterial), mAb (A57-E4) (antibody)

RRID:AB_10539940

This monoclonal targets HSP60 (bacterial) mAb (A57-E4)

View all literature mentions

Phospho-ETS1 (Ser282) Polyclonal Antibody (antibody)

RRID:AB_2533577

This unknown targets Phospho-ETS1 (Ser282)

View all literature mentions

p-Tyr (PY99) (antibody)

RRID:AB_628123

This monoclonal targets p-Tyr (PY99)

View all literature mentions

FRA1 antibody [EP4711] (antibody)

RRID:AB_11001005

This monoclonal targets FRA1 antibody [EP4711]

View all literature mentions

ETS1 antibody (antibody)

RRID:AB_10975199

This polyclonal targets ETS1 antibody

View all literature mentions

Anti-Phosphoserine (antibody)

RRID:AB_390205

This polyclonal targets Phosphoserine

View all literature mentions

HeLa (cell line)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions